Genetec Corp. (4492) Stock Statistics & Valuation Metrics

Genetec Corp. has a market cap or net worth of ¥5.36B. The enterprise value is ¥5.54B.

Genetec Corp. has 11,727,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Genetec Corp.’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 8.33%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Genetec Corp. had revenue of 8.12B and earned 421.12M in profits. Earnings per share was 36.81.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Genetec Corp. pays an annual dividend of ¥18, resulting in a dividend yield of 3.89%

Genetec Corp. upcoming earnings date is ―, ―.

Genetec Corp. as a current ratio of 1.39, with Debt / Equity ratio of 93.99%

In the past 12 months, Genetec Corp. has paid 240.94M in taxes.

Genetec Corp. EV to EBITDA ratio is 7.56, with an EV/FCF ratio of 16.29.

Genetec Corp. has ¥1.43B in cash and marketable securities with ¥1.09B in debt, giving a net cash position of -¥343.00M billion.

Gross margin is 40.27%, with operating margin of 8.54%, and net profit margin of 5.18%.

The average price target for Genetec Corp. is ¥477.00, which is 11.43% higher than the current price. The consensus rating is Hold